These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 21364138)

  • 1. Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial.
    Gladwin MT; Kato GJ; Weiner D; Onyekwere OC; Dampier C; Hsu L; Hagar RW; Howard T; Nuss R; Okam MM; Tremonti CK; Berman B; Villella A; Krishnamurti L; Lanzkron S; Castro O; Gordeuk VR; Coles WA; Peters-Lawrence M; Nichols J; Hall MK; Hildesheim M; Blackwelder WC; Baldassarre J; Casella JF;
    JAMA; 2011 Mar; 305(9):893-902. PubMed ID: 21364138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease.
    Weiner DL; Hibberd PL; Betit P; Cooper AB; Botelho CA; Brugnara C
    JAMA; 2003 Mar; 289(9):1136-42. PubMed ID: 12622584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled nitric oxide for treating pain crises in people with sickle cell disease.
    Aboursheid T; Albaroudi O; Alahdab F
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD011808. PubMed ID: 35802341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of nitric oxide breathing in adult patients with sickle cell crisis.
    Head CA; Swerdlow P; McDade WA; Joshi RM; Ikuta T; Cooper ML; Eckman JR
    Am J Hematol; 2010 Oct; 85(10):800-2. PubMed ID: 20799359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
    Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled nitric oxide for acute chest syndrome in adult sickle cell patients: a randomized controlled study.
    Maitre B; Djibre M; Katsahian S; Habibi A; Stankovic Stojanovic K; Khellaf M; Bourgeon I; Lionnet F; Charles-Nelson A; Brochard L; Lemaire F; Galacteros F; Brun-Buisson C; Fartoukh M; Mekontso Dessap A
    Intensive Care Med; 2015 Dec; 41(12):2121-9. PubMed ID: 26431718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled nitric oxide for treating pain crises in people with sickle cell disease.
    Aboursheid T; Albaroudi O; Alahdab F
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD011808. PubMed ID: 31603241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
    Casella JF; Barton BA; Kanter J; Black LV; Majumdar S; Inati A; Wali Y; Drachtman RA; Abboud MR; Kilinc Y; Fuh BR; Al-Khabori MK; Takemoto CM; Salman E; Sarnaik SA; Shah N; Morris CR; Keates-Baleeiro J; Raj A; Alvarez OA; Hsu LL; Thompson AA; Sisler IY; Pace BS; Noronha SA; Lasky JL; de Julian EC; Godder K; Thornburg CD; Kamberos NL; Nuss R; Marsh AM; Owen WC; Schaefer A; Tebbi CK; Chantrain CF; Cohen DE; Karakas Z; Piccone CM; George A; Fixler JM; Singleton TC; Moulton T; Quinn CT; de Castro Lobo CL; Almomen AM; Goyal-Khemka M; Maes P; Emanuele M; Gorney RT; Padgett CS; Parsley E; Kronsberg SS; Kato GJ; Gladwin MT
    JAMA; 2021 Apr; 325(15):1513-1523. PubMed ID: 33877274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group.
    Dellinger RP; Zimmerman JL; Taylor RW; Straube RC; Hauser DL; Criner GJ; Davis K; Hyers TM; Papadakos P
    Crit Care Med; 1998 Jan; 26(1):15-23. PubMed ID: 9428538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Biemond BJ; Tombak A; Kilinc Y; Al-Khabori M; Abboud M; Nafea M; Inati A; Wali Y; Kristensen J; Kowalski J; Donnelly E; Ohd J;
    Lancet Haematol; 2021 May; 8(5):e334-e343. PubMed ID: 33894169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial.
    Orringer EP; Casella JF; Ataga KI; Koshy M; Adams-Graves P; Luchtman-Jones L; Wun T; Watanabe M; Shafer F; Kutlar A; Abboud M; Steinberg M; Adler B; Swerdlow P; Terregino C; Saccente S; Files B; Ballas S; Brown R; Wojtowicz-Praga S; Grindel JM
    JAMA; 2001 Nov; 286(17):2099-106. PubMed ID: 11694150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
    Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
    Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease.
    Al Hajeri A; Serjeant GR; Fedorowicz Z
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD006957. PubMed ID: 18254121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methemoglobin and nitric oxide therapy in Ugandan children hospitalized for febrile illness: results from a prospective cohort study and randomized double-blind placebo-controlled trial.
    Conroy AL; Hawkes M; Hayford K; Hermann L; McDonald CR; Sharma S; Namasopo S; Opoka RO; John CC; Liles WC; Miller C; Kain KC
    BMC Pediatr; 2016 Nov; 16(1):177. PubMed ID: 27814710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome.
    Morris CR; Kuypers FA; Larkin S; Vichinsky EP; Styles LA
    J Pediatr Hematol Oncol; 2000; 22(6):515-20. PubMed ID: 11132219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial.
    Taylor RW; Zimmerman JL; Dellinger RP; Straube RC; Criner GJ; Davis K; Kelly KM; Smith TC; Small RJ;
    JAMA; 2004 Apr; 291(13):1603-9. PubMed ID: 15069048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.
    Morris CR; Kuypers FA; Lavrisha L; Ansari M; Sweeters N; Stewart M; Gildengorin G; Neumayr L; Vichinsky EP
    Haematologica; 2013 Sep; 98(9):1375-82. PubMed ID: 23645695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
    Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
    van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
    Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.
    Dampier CD; Smith WR; Wager CG; Kim HY; Bell MC; Miller ST; Weiner DL; Minniti CP; Krishnamurti L; Ataga KI; Eckman JR; Hsu LL; McClish D; McKinlay SM; Molokie R; Osunkwo I; Smith-Whitley K; Telen MJ;
    Clin Trials; 2013 Apr; 10(2):319-31. PubMed ID: 23539110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.